Boswellia Serrata (AKBA)

Accelerate your CDMO or DTC pipeline. Map the exact physiochemical constraints, bioavailability synergies, and optimal delivery mechanisms for Boswellia Serrata (AKBA).

Boswellia serrata extract functions as a potent, non-redox inhibitor of 5-lipoxygenase (5-LOX), effectively downregulating leukotriene biosynthesis to manage chronic inflammatory pathologies such as osteoarthritis and asthma.

Verified Molecular Profiling (NIH PubChem)

PubChem CID

11386458

Molecular Weight

498.7 g/mol

XLogP3 (Lipophilicity)

8.3

IUPAC Name

(3R,4R,4aR,6aR,6bS,8aR,11R,12S,12aR,14aR,14bR)-3-acetyloxy-4,6a,6b,8a,11,12,14b-heptamethyl-2,3,4a,5,6,7,8,9,10,11,12,12a,14,14a-tetradecahydro-1H-picene-4-carboxylic acid

Pharmacokinetic Synergies & Enhancers

Proven Synergy Pairings

Curcumin for [Dual-pathway inhibition of COX-2 and 5-LOX enzymes]
Glucosamine for [Synergistic chondroprotection and reduction of cartilage degradation markers]

Biological Formulation Enhancers

Phosphatidylcholine for [Formation of phytosome complexes to increase the bioavailability of lipophilic boswellic acids]
Piperine for [Inhibition of metabolic glucuronidation to prolong systemic circulation of AKBA]

Delivery System Constraints & Modeling

Every active compound behaves uniquely based on the physical matrix it is suspended in. Below are the known physical chemistry challenges for Boswellia Serrata (AKBA) across standard consumer modalities.

💊 Standard Capsules

The resinous nature of the extract can cause significant flowability issues and mechanical sticking in high-speed encapsulation equipment, necessitating precise glidant ratios.

🍬 Gummy & Pectin Formats

The inherent bitterness and hydrophobic resin profile of the extract pose significant challenges for flavor masking and achieving a homogenous suspension within a hydrophilic pectin or gelatin matrix.

🔬 Thin-Film Oral Strips

The substantial therapeutic dose required for clinical efficacy typically exceeds the physical payload capacity of thin-film polymers, which are generally limited to low-milligram active ingredients.

For Brand Founders

Formulate with Boswellia Serrata (AKBA)

Ready to launch a product featuring Boswellia Serrata (AKBA)? Skip months of expensive wet-lab iterations. Generate a manufacturer-ready formulation in hours, instantly screened for physical incompatibilities and global regulatory compliance.

Build Science-Backed Formulation

Efficacy Evidence

Maximize Boswellia Serrata (AKBA) Bioavailability

Need absolute proof that your Boswellia Serrata (AKBA) extract actually absorbs? Stop blindly combining generic powders. Run a physics-based PBPK simulation to mathematically engineer peak clinical efficacy and targeted plasma concentrations.

Simulate Bioavailability

For R&D Labs & CDMOs

Boswellia Serrata (AKBA) Degradation Testing

Is your Boswellia Serrata (AKBA) payload degrading in the capsule before the expiration date? Stop waiting for costly bench testing. Run an accelerated digital twin to precisely model oxidation pathways and pH shifts before finalizing a manufacturing run.

Model Active Degradation